Comparing Poly (ADP-Ribose) Polymerase Inhibitors With Standard Chemotherapy in BRCA-Mutated, Recurrent Ovarian Cancer: Lessons Learned From a Negative Trial

[摘要]：

[全文传递流程]：

一般上传文献全文的时限在1个工作日内